Please provide your email address to receive an email when new articles are posted on . In refractive and cataract surgery, femtosecond lasers have increased precision and reduced complications. They ...
FREMONT, Calif.--(BUSINESS WIRE)--Nova Eye Medical Limited, a medical technology company committed to advanced ophthalmic treatment technologies and devices, is pleased to announce the peer review ...
ViaLase, a medical technology startup developing a new femtosecond laser treatment for glaucoma, has closed its series C funding round with $40 million in additional finance. Based in Alisa Viejo, ...
March 20, 2012 (New York, New York) — An investigation into the effects of calcium and iron supplementation on ocular health has found that consuming high amounts of these supplements leads to an ...
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager™ DSLT, the ...
California-based medical technology startup ViaLase has announced that its ViaLase Laser device for glaucoma treatment has received CE mark approval. The approval moves the platform towards ...
A Meta-Analysis of 22 Studies, and Data from the IRIS® Registry Highlighting Clinical Outcomes in Real-World Clinical Practice, Demonstrates Significant, Long-Term IOP Reduction and Medication ...
The CDC reports that over three million Americans have glaucoma. The number may reach 6.3 million by 2050 as the aging population grows. Glaucoma is affecting so many lives, so it’s important to know ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback